These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 6332766)

  • 1. [Psychopathometric cross sectional study in aged chronic schizophrenic patients].
    Benos J
    Fortschr Neurol Psychiatr; 1984 Jul; 52(7):223-36. PubMed ID: 6332766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rorschach response process in schizophrenia].
    Harada N
    Seishin Shinkeigaku Zasshi; 1996; 98(6):378-412. PubMed ID: 8810861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Performance-psychologic cross-sectional study of young schizophrenic patients with a subchronic and chronic disease course].
    Milech U; Böning J; Classen W
    Psychiatr Neurol Med Psychol (Leipz); 1990 Jul; 42(7):385-93. PubMed ID: 2236350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Working memory impairments in first-episode psychosis and chronic schizophrenia.
    Zanello A; Curtis L; Badan Bâ M; Merlo MC
    Psychiatry Res; 2009 Jan; 165(1-2):10-8. PubMed ID: 19046607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mass of flesh: schizophrenic Rorschach percepts.
    Koide R; Chien CP; Iizuka S; Morita N
    Compr Psychiatry; 2002; 43(6):474-7. PubMed ID: 12439836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in schizophrenia as seen in the Rorschach test.
    Danielsson K; Flyckt L; Edman G
    Nord J Psychiatry; 2001; 55(2):137-42. PubMed ID: 11802912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological aspects and learning processes in schizophrenic patients.
    Penati G; Maffei C; Fornari MG; Ponzano M; Resele LF; Scarone S
    Act Nerv Super (Praha); 1977 Jul; 19 Suppl 2():418-25. PubMed ID: 551685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Frontal lobe cognition disorders in 42 schizophrenic patients compared with 19 normal probands].
    Jaquet I; Lançon C; Auquier P; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):34-41. PubMed ID: 9172966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intellectual performance of chronic schizophrenic patients.
    Zampera E
    Coll Antropol; 1999 Dec; 23(2):597-602. PubMed ID: 10646233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between the general intellect of schizophrenic patients and psychopathological deterioration.
    Chkonia E; Roinishvili M; Kereselidze M; Makhatadze N
    Georgian Med News; 2009 Mar; (168):60-3. PubMed ID: 19359723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of RBANS test (Repeatable Battery for the Assessment of Neuropsychological Status) in neurocognitive testing of patients suffering from schizophrenia and dementia].
    Juhász LZ; Kemény K; Linka E; Sántha J; Bartkó G
    Ideggyogy Sz; 2003 Sep; 56(9-10):303-8. PubMed ID: 14608951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of the tree-drawing test in chronic schizophrenia.
    Kaneda A; Yasui-Furukori N; Saito M; Sugawara N; Nakagami T; Furukori H; Kaneko S
    Psychiatry Clin Neurosci; 2010 Apr; 64(2):141-8. PubMed ID: 20447010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The P 300 potential in schizophrenia].
    Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
    Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological dysfunction in schizophrenia and affective disease.
    Taylor MA; Redfield J; Abrams R
    Biol Psychiatry; 1981 May; 16(5):467-78. PubMed ID: 7272376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive impairment of chronic schizophrenics does not equate to dementia].
    Schenker T; Fischer RB
    Psychiatr Prax; 2000 Mar; 27(2):102. PubMed ID: 10738743
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of cognitive performance in schizophrenia patients and healthy individuals with unsupervised clustering models.
    Silver H; Shmoish M
    Psychiatry Res; 2008 May; 159(1-2):167-79. PubMed ID: 18440074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.